As we pursue the development of proposed solutions for the implementation and use of CDISC SEND (Clinical Data Interchange Standards Consortium) (Standard for Exchange of Nonclinical Data) data packages with the aim of facilitating cross-study analysis, we plan to share our progress through various public channels like manuscripts, Congress presentations, and forums as well as webinars and workshops. We invite you to read about our development work below and get information about upcoming events and progress by joining our mailing list.
Harmonization of SEND Implementation to Enable Historical Control Data Analysis, the Recommendations for Populating Control Type (TCNTRL) with CDISC SEND Controlled Terminology
2021 White Paper in PHUSEDownload Now
Leveraging the Value of CDISC SEND Datasets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals
2021 Manuscript in Chemical Research & Toxicology.
The SEND Harmonization for Cross-Study Analysis team has published a second manuscript co-authored in collaboration with the FDA under the Public-Private Partnership in Chemical Research in Toxicology’s Computational Toxicology Special Edition (Chem. Res. Toxicol. 2021, 34, 2, 483–494).
SEND harmonization & cross-study analysis: A proposal to better harvest the value from SEND data
2020 Manuscript in Regulatory Toxicology & Pharmacology.Download Now
2019 Luncheon & Overview, “SEND Harmonization Initiative Solutions to Enable Cross-Study Analysis”
Additionally, minutes from the workshop can be accessed here.Download Now